Provided by Tiger Trade Technology Pte. Ltd.

MODERN CHI MED

0.850
+0.0303.66%
Volume:618.00K
Turnover:495.24K
Market Cap:612.00M
PE:-35.53
High:0.850
Open:0.780
Low:0.780
Close:0.820
52wk High:3.260
52wk Low:0.485
Shares:720.00M
HK Float Shares:720.00M
Volume Ratio:4.24
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.024
ROE:-2.76%
ROA:-1.91%
PB:1.05
PE(LYR):-35.53
PS:3.61

Loading ...

Modern Chinese Medicine flags RMB25.90 million first-half 2026 loss as marketing and R&D costs climb

Bulletin Express
·
Aug 21

Modern Chinese Medicine Group Flags Expected Interim Loss of Approximately RMB 25.9 Million

Stock News
·
Aug 21

Modern Chinese Medicine Expects RMB 25.9 Million H1 Net Loss vs RMB 2.5 Million Profit a Year Earlier

Reuters
·
Aug 21

Modern Chinese Medicine Group Co - Expects Net Loss of Rmb25.9 Mln for Six Months Ended June 2026

THOMSON REUTERS
·
Aug 21

Modern Chinese Medicine Group Co - Hy Net Loss Mainly Due to Increased Promotion, Marketing, Research and Development Expenses

THOMSON REUTERS
·
Aug 21

Modern Chinese Medicine Sets 28 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend

Bulletin Express
·
Aug 13

Modern Chinese Medicine Group Sets Board Meeting to Review Interim Results, Dividend Recommendation

Reuters
·
Aug 13

Modern Chinese Medicine Reports Stable Share Capital and Sufficient Public Float for July 2026

Bulletin Express
·
Aug 03

Modern Chinese Medicine Group to Buy 30% Stake in AI Health Global for HK$ 41.82 Million

Reuters
·
Jun 26

MODERN CHI MED Finalises Third Amended & Restated Memorandum and Articles; Authorised Share Capital Fixed at HK$100 Million

Bulletin Express
·
May 29

Modern Chinese Medicine Schedules 29 May 2026 AGM; Seeks Approval of FY 2025 Accounts, Director Re-elections and Share Mandates

Bulletin Express
·
May 08

MODERN CHI MED obtains Stock Exchange waiver, extends major-transaction circular deadline to 30 June 2026

Bulletin Express
·
May 07

Modern Chinese Medicine Group delays circular despatch to 30 June 2026, seeks Listing Rules waiver

Bulletin Express
·
Apr 30

MODERN CHI MED业绩承压:2025年营收约1.452亿元同比降32.2%,净亏损0.136亿元并推进港澳市场布局

Bulletin Express
·
Apr 28

Modern Chinese Medicine schedules 2026 AGM; seeks shareholder approval for director re-elections, 10% buy-back mandate and new Articles

Bulletin Express
·
Apr 28

MODERN CHI MED Proposes Third Amended Articles to Enable Electronic Communication, Hybrid Meetings and Digital Payments

Bulletin Express
·
Apr 28

MODERN CHI MED Tables 2026 AGM Proposals for 10% Buy-back Mandate, 20% Issuance Mandate and Articles Update

Bulletin Express
·
Apr 28

Modern Chinese Medicine Group publishes 2025 annual report

Reuters
·
Apr 28

Modern Chinese Medicine Group announces annual general meeting

Reuters
·
Apr 28

Modern Chinese Medicine proposes bylaws to allow electronic, hybrid shareholder meetings

Reuters
·
Apr 28